English Polski
Vol 10, No 3 (2017)
Conference report / Report
Published online: 2017-10-25

open access

Page views 329
Article views/downloads 2253
Get Citation

Connect on Social Media

Connect on Social Media

Therapeutic apheresis in view of data presented during the 27th Regional Congress of the International Society of Blood Transfusion in Copenhagen (17–21 June 2017)

Aleksandra Rosiek1
Journal of Transfusion Medicine 2017;10(3):99-106.

Abstract

xx

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Fernandes AA, Antunes M, Caiado A, et al. Therapeutic apheresis – a center experience. Vox Sanguinis. 2017; 112(supl.1): 254.
  2. Kirov Z. Rationalization and optimization of the therapeutic plasma exchange application. Vox Sanguinis. 2017; 112(supl.1): 253.
  3. Esesumaga A, Borges C, Tomaz J. Paraneoplastic neurological syndrome (PNS): three case reports with therapeutic plasma exchange (TPE). Vox Sanguinis. 2017; 112(supl.1): 252.
  4. Mottola M, Arcopinto C, Brighel F, et al. Treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIPD) with plasmaexchange: short-term response case report. Vox Sanguinis. 2017; 112(supl.1): 253.
  5. Hwang N, Kim Z, Ham J, et al. Relapsed neuromyelitis optica spectrum disorder, successfully treated by therapeutic plasma exchange: a case report. Vox Sanguinis. 2017; 112(supl.1): 253.
  6. Lee H, Shin K, Lee S, et al. Increasing use of therapeutic apheresis as a liversaving modality. Vox Sanguinis. 2017; 112(supl.1): 251.
  7. Kakkar B, Makroo R, Agrawal S, et al. Role of therapeutic plasma exchange in antibody mediated rejection in live related renal transplantation. Vox Sanguinis. 2017; 112(supl.1): 251.
  8. Sachan D, Verghese J, Saha S, et al. Role of therapeutic plasma exchange (TPE) in patients with drug induced liver injury. Vox Sanguinis. 2017; 112(supl.1): 252.
  9. Senanayake W, Abeysinghe P, Sumanasekera RA. case report: the efficacy of therapeutic plasma exchange in the management of a patient with atypical presentation of thrombotic thrombocytopenic purpura. Vox Sanguinis. 2017; 112(supl.1): 254.
  10. Khetarpal K, Kotwal U. Role of automated therapeutic red cell exchange in the setting of acute methemoglobinemia – our experience. Vox Sanguinis. 2017; 112(supl.1): 254.
  11. Cannizzo E, Spadola V, Saeli A, et al. Patients with sickle cell disease treated with red blood cells exchange: the experience of Ragusa SIMT. Vox Sanguinis. 2017; 112(supl.1): 255.
  12. Koranova M, Bohonek M, Hrabanek J, et al. Polyglobulia – venesection and double red cell apheresis treatment. Vox Sanguinis. 2017; 112(supl.1): 255.
  13. Sardo R, Preto R, Esesumaga A, et al. Erythrocytapheresis and phlebotomy to treat red blood cell (RBC) disorders: review from the cellular therapy and apheresis unit of Coimbra Hospital And University Center (CHUC), 2006 to 2016. Vox Sanguinis. 2017; 112(supl.1): 255.
  14. Orlando N, Iachininoto M, Valentini C, et al. Evaluation of the apoptotic effects of extracorporeal photopheresis for the treatment of chronic graft-vs-host disease. Vox Sanguinis. 2017; 112(supl.1): 251.
  15. Grzasko N, Morawska M, Hus M. Optimizing the treatment of patients with multiple myeloma and renal impairment. Clin Lymphoma Myeloma Leuk. 2015; 15(4): 187–198.
  16. Schwartz J, Padmanabhan A, Aqui N, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apher. 2016; 31(3): 149–162.